In conclusion, our results demonstrate that TRUB1 is not only upregulated in CRC, but also serves as a promising biomarker for both CRC identification and prognosis, with higher expression levels associated with worse clinical outcomes. This evidence concerns the gene TRUB1 and colorectal carcinoma.